tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SURF

SURF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsSURF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10M ago
SURF
Coherus Biosciences completes Surface Oncology acquisition
PremiumThe Fly
Coherus Biosciences completes Surface Oncology acquisition
1y ago
CHRS
SURF
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
PremiumPress Releases
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
1y ago
SURF
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
PremiumPress Releases
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
1y ago
SURF
Surface Oncology reports Q2 EPS (46c), consensus (34c)
PremiumThe Fly
Surface Oncology reports Q2 EPS (46c), consensus (34c)
1y ago
SURF
Surface Oncology downgraded to Hold from Buy at JonesResearch
PremiumThe FlySurface Oncology downgraded to Hold from Buy at JonesResearch
1y ago
SURF
Coherus Biosciences price target lowered to $22 from $24 at Truist
Premium
The Fly
Coherus Biosciences price target lowered to $22 from $24 at Truist
1y ago
CHRS
SURF
Surface Oncology downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Surface Oncology downgraded to Neutral from Outperform at Wedbush
1y ago
SURF
Surface Oncology downgraded to Neutral from Outperform at Baird
PremiumThe Fly
Surface Oncology downgraded to Neutral from Outperform at Baird
1y ago
CHRS
SURF
Surface Oncology downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Surface Oncology downgraded to Neutral from Buy at H.C. Wainwright
1y ago
CHRS
SURF
Surface Oncology implements 50% workforce reduction
PremiumThe Fly
Surface Oncology implements 50% workforce reduction
1y ago
CHRS
SURF
Coherus Biosciences to acquire Surface Oncology in stock for stock transaction
PremiumThe Fly
Coherus Biosciences to acquire Surface Oncology in stock for stock transaction
1y ago
GSK
NVS
Coherus to Acquire Surface Oncology
PremiumPress ReleasesCoherus to Acquire Surface Oncology
1y ago
SURF
Coherus Biosciences, Surface Oncology enter definitive merger agreement
Premium
The Fly
Coherus Biosciences, Surface Oncology enter definitive merger agreement
1y ago
CHRS
SURF
Surface Oncology (SURF) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Surface Oncology (SURF) Q1 Earnings Cheat Sheet
1y ago
SURF
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
PremiumPress Releases
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
1y ago
SURF
Surface Oncology presents new preclinical data on SRF114
PremiumThe Fly
Surface Oncology presents new preclinical data on SRF114
1y ago
SURF
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
PremiumPress Releases
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
1y ago
SURF
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023 
PremiumPress Releases
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023 
2y ago
SURF
Surface Oncology announces anticipated near-term corporate milestones
PremiumThe FlySurface Oncology announces anticipated near-term corporate milestones
2y ago
SURF
Surface Oncology sees cash runway into 3Q24
Premium
The Fly
Surface Oncology sees cash runway into 3Q24
2y ago
SURF
Surface Oncology reports Q4 EPS (35c), consensus (33c)
Premium
The Fly
Surface Oncology reports Q4 EPS (35c), consensus (33c)
2y ago
SURF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >